Alice Pomponio is managing director of BrightEdge, the American Cancer Society's venture capital and impact investment arm. BrightEdge invests in for-profit companies developing therapeutics, diagnostics, medical devices and technologies to eradicate cancer. It invests alongside top-tier life sciences and healthcare investors with a goal of generating financial returns and patient impact.
It is critical that we rightsize and redistribute available funds based on our knowledge of persistent cancer disparities to help more patients benefit from potentially lifesaving innovations and ensure no one is left behind.